| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIAA1549L mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIAA1549L mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIAA1549L mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIAA1549L mRNA" | 27188386 |
| D001280 | Atrazine | Atrazine results in decreased expression of KIAA1549L mRNA | 22378314 |
| C487081 | belinostat | belinostat results in decreased expression of KIAA1549L mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIAA1549L mRNA" | 27188386 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KIAA1549L mRNA" | 20382639 |
| D004958 | Estradiol | Estradiol affects the expression of KIAA1549L mRNA | 14699072 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of KIAA1549L mRNA | 25181051 |
| C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KIAA1549L mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KIAA1549L mRNA | 28628672 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of KIAA1549L mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of KIAA1549L mRNA | 27392435 |
| D004317 | Doxorubicin | KIAA1549L protein affects the susceptibility to Doxorubicin | 16217747 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KIAA1549L mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KIAA1549L mRNA | 28628672 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of KIAA1549L mRNA | 27392435 |
| C561695 | (+)-JQ1 compound | [(+)-JQ1 compound co-treated with PD 0325901] results in decreased expression of KIAA1549L mRNA | 25119042 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of KIAA1549L mRNA | 25119042 |
| C482199 | lipopolysaccharide, E coli O55-B5 | "lipopolysaccharide, E coli O55-B5 results in increased expression of KIAA1549L mRNA" | 24972896 |
| C506614 | PD 0325901 | [(+)-JQ1 compound co-treated with PD 0325901] results in decreased expression of KIAA1549L mRNA | 25119042 |
| C506614 | PD 0325901 | PD 0325901 results in decreased expression of KIAA1549L mRNA | 25119042 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIAA1549L mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of KIAA1549L mRNA | 26272509 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of KIAA1549L mRNA | 23557933 |
| C005556 | propionaldehyde | propionaldehyde results in increased expression of KIAA1549L mRNA | 26079696 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in increased expression of KIAA1549L mRNA | 25895662 |
| C012589 | trichostatin A | trichostatin A results in increased expression of KIAA1549L mRNA | 24935251 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of KIAA1549L mRNA | 23179753|2718838 |
| C111237 | vorinostat | vorinostat results in decreased expression of KIAA1549L mRNA | 27188386 |